Cambridge Medical Technology
Country not established
- Devices
- 14
What Cambridge Medical Technology makes
Cambridge Medical Technology produces diagnostic radioimmunoassay (RIA) kits and matched component sets for measuring hormones and biomarkers, including digoxin, thyroid hormones (T3, T4), cortisol, progesterone, insulin, and ferritin. Their products are designed for laboratory use to quantify specific substances in patient samples, supporting clinical assessments in endocrinology, cardiology, and hematology.
The company’s portfolio includes Class I and Class II devices, with several products authorised via the FDA’s 510(k) pathway. These diagnostic tools are listed in the FDA’s 510(k) registry, adhering to US regulatory requirements for in vitro diagnostics. The manufacturer operates from the United States.
Catalogue
Search and filter all 14 devicesFrequently asked questions
How many devices does Cambridge Medical Technology have in the registry?
The registry currently lists 14 devices for Cambridge Medical Technology. Devices recorded under merged duplicate company entries are counted once.
Which registries list Cambridge Medical Technology's devices?
Among its 14 most recently registered devices, Cambridge Medical Technology has devices listed in FDA 510(k) (14 devices).
What risk classes do Cambridge Medical Technology's devices fall under?
Among its 14 most recently registered devices, the classes recorded for Cambridge Medical Technology's devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Cambridge Medical Technology in the registry?
The most recently registered devices listed for Cambridge Medical Technology include MATCHED COMPONENT SET FOR DIGITOXIN, PARATHYROID HORMONE RADIOIMMUNOASSAY KIT, NO SPIN(TM) T3 COATED TUBE RADIOIMMUNOASSAY and MATCHED COMPONENT SET FOR RADIOIMMUNO-.